Navigation Links
Questcor Pharmaceuticals Announces Preliminary Operating Metrics for Third Quarter 2011
Date:9/28/2011

inue," "could," "estimates," "expects," "growth," "may," "plans," "potential," "should," "substantial" or "will" or the negative of such terms and other comparable terminology. These statements are only predictions. Actual events or results may differ materially. Factors that could cause or contribute to such differences include, but are not limited to, the following:

  • Our reliance on Acthar for substantially all of our net sales and profits;
  • Reductions in vials used per prescription resulting from changes in treatment regimens by physicians or patient compliance with physician recommendations;
  • The complex nature of our manufacturing process and the potential for supply disruptions or other business disruptions;
  • The lack of patent protection for Acthar, and the possible FDA approval and market introduction of competitive products;
  • Our ability to generate revenue from sales of Acthar to treat on-label indications associated with NS, and our ability to develop other therapeutic uses for Acthar including systemic lupus erythematosus;
  • Research and development risks, including risks associated with Questcor's work in the area of NS and potential work in the area of systemic lupus erythematosus, and our reliance on third-parties to conduct research and development and the ability of research and development to generate successful results;
  • Regulatory changes or other policy actions by governmental authorities and other third parties in connection with U.S. health care reform or efforts to reduce federal and state government deficits;
  • Our ability to receive high reimbursement levels from third party payers;
  • An increase in the proportion of our Acthar unit sales comprised of Medicaid-eligible patients and government entities;
  • Our ability to estimate reserves required for Acthar used by government entities and Medicaid-eligible patients, and the impact that unfore
    '/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Questcor Pharmaceuticals to Present at the Jefferies Global Healthcare Conference on September 28, 2011
2. Questcor Provides Updated New Paid Prescription Trends
3. UPDATING and ADDING: Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September
4. Questcor Pharmaceuticals to Present at the Canaccord Genuity Growth Conference on August 11, 2011
5. Questcor to Report Second Quarter 2011 Earnings and Conduct Conference Call on July 26, 2011
6. Questcor Proxy Proposals All Approved at 2011 Shareholder Meeting
7. Questcor Discusses ISS Proxy Recommendations; Provides Business Update
8. Questcor to Report First Quarter 2011 Earnings and Conduct Conference Call on April 26, 2011
9. Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011
10. Questcor Pharmaceuticals to Present at the Needham Healthcare Conference
11. Questcor Pharmaceuticals to Present at the Barclays Capital Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... Intarcia Therapeutics, Inc. today ... into the newly created role of Chief Operating ... executive with world-class experience – most recently at ... at industry leaders such as Pfizer and Bristol ... of therapeutic areas, including: cardiovascular, metabolic, oncology, neuroscience, ...
(Date:5/4/2015)... , May 4, 2015 CytoSorbents Corporation ... commercializing its CytoSorb® extracorporeal cytokine adsorber to treat ... worldwide, will report Q1 2015 financial results after ... CytoSorbents, management will host a ... recount both operational and financial progress during Q1 ...
(Date:5/4/2015)... May 4, 2015  Caris Life Sciences®, a ... of precision medicine, today announced the designation of ... in the Caris Centers of Excellence for Precision ... Maryland and the ... a leader in oncology research and treatment, with ...
Breaking Medicine Technology:Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 2Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 3Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 4CytoSorbents to Report Q1 2015 Operating and Financial Results 2CytoSorbents to Report Q1 2015 Operating and Financial Results 3Caris Life Sciences Designates MedStar Health a Caris Center of Excellence 2Caris Life Sciences Designates MedStar Health a Caris Center of Excellence 3
... , , Agency Experts ... , SILVER SPRING, Md., Dec. 23 As part of its ... FDA has scheduled a series of workshops about orphan drug designation ... FDA can grant a special status, known as orphan designation, for ...
... , BOSTON, Dec. 23 Solos Endoscopy, Inc. (Pink ... has outlined its 2010 marketing strategy as developed by ... marketing campaign will focus primarily on the MammoView(TM) line. ... medical publications, development of a media-advertising program, production of ...
Cached Medicine Technology:FDA: Orphan Drug Workshops Scheduled For Feb. 25-26 and Aug. 3-4, 2010 2Solos Endoscopy, Inc. Outlines Marketing Strategy for 2010 Campaign 2
(Date:5/4/2015)... Ticket Down is a reputable source for authentic ... While the World Cup is the most known soccer ... the International Champions Cup is one of the biggest tournaments ... record for soccer in the United States set when Manchester ... University of Michigan. This year, the defending champion Manchester United ...
(Date:5/4/2015)... May 04, 2015 Los Angeles ... offering a more comfortable and attractive alternative for patients ... choice for those who have lost teeth. Unfortunately, they ... insecure or slip at the worst possible moment and ... talks. They can also painfully pinch or rub gums, ...
(Date:5/4/2015)... New findings released today from a poll conducted ... people diagnosed with a brain tumor needed more information ... at the time of diagnosis, and had only a ... course of treatment. The release of these findings corresponds ... volunteer network, the ABTA CommYOUnity™, dedicated to serving the ...
(Date:5/4/2015)... May 04, 2015 San Diego ... ceremony at their brand new, 13,700 square foot facility ... new building will not only provide fertility treatment and ... also offer community and educational events to a number ... is located next door to their current Carmel Valley/Del ...
(Date:5/4/2015)... MT (PRWEB) May 04, 2015 New ... with Care to Care, LLC to manage outpatient advanced ... help New West Medicare ensure its members are provided ... unnecessary radiation. , Working closely with New West Medicare’s ... promoting the safe use of advanced imaging and provide ...
Breaking Medicine News(10 mins):Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 2Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 3Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 4Health News:Los Angeles Dental Implants Doctor, Kevin Sands DDS, Now Offers a More Comfortable and Aesthetically-Pleasing Solution to Denture-Wearers 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 3Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 3Health News:New West Medicare Partners with Care to Care, LLC to Manage Advanced Imaging Services 2
... among college students has long been viewed as ... spend millions of dollars annually on public service ... hazardous drinking habits. These organizations primarily use "loss-framed", ... binge drinking. Now, University of Missouri researchers have ...
... HealthDay Reporter , WEDNESDAY, June 1 (HealthDay News) -- ... for decades by millions of people -- may eventually have ... studies. One study suggests that women who are already ... diagnosed with breast cancer at an earlier stage of the ...
... a hospital is readmitted within a month. Seeking to ... door hospital readmissions, the Affordable Care Act proposes a ... and reduce costs for the growing population of chronically ... a central theme in these provisions, there is little ...
... The Reed Elsevier Environmental Challenge aims to encourage innovative ... supply for communities where it is presently at risk. ... announced today, is Tagore-SenGupta Foundation. Their project involves installation ... and schools in Cambodia where arsenic groundwater contamination is ...
... recently published paper highlights that while the risk of post-traumatic ... than those without migraine irrespective of sex, the risk is ... now available in Headache: The Journal of Head and ... American Headache Society. In this paper, lead author ...
... other technologies harnessing health data to improve people,s and ... Initiative Forum, hosted by the Institute of Medicine and ... June 9. IT developers, health policy experts, company ... by the Institute of Medicine and U.S. Department of ...
Cached Medicine News:Health News:College students respond better to positive anti-binge drinking messages 2Health News:Widely Used Heart Drugs Linked to Better Breast Cancer Outcomes 2Health News:Widely Used Heart Drugs Linked to Better Breast Cancer Outcomes 3Health News:Reducing revolving door hospital re-admissions 2Health News:Reed Elsevier Environmental Challenge winners announced 2Health News:Sex matters -- more men with migraine suffer from PTSD than women 2Health News:Sex matters -- more men with migraine suffer from PTSD than women 3Health News:Health data forum features dynamic apps, experts on June 9 2
This is an Immunological assay intended for the quantitative in vitro determination of haemoglobin A1c (HbA1c) in whole blood....
For the quantitative in vitro determination of Ammonia in plasma...
For the quantitative in vitro determination of Sodium in serum and plasma....
Enzymatic assay for the quantitative in vitro determination of glycated protein (fructosamine) in human serum or plasma....
Medicine Products: